By Sriram Prakash, Irina Bolotnikova, Haranath Sriyapureddy – Deloitte Contributors: Ben Davies, James Anson-Smith, Jo Brealey, Kristie Ampuero About The Deloitte M&A Index The Deloitte M&A Index is a
by Elsevier Ltd.
Despite prevailing financial turmoil and economic uncertainty, global M&A market has shown in 2014 an unseen growth since sub-prime crisis. The research focuses on reaching understanding and reconstructions on how management and corporate strategists can benefit from opportunities arising during various economic cycles. […] Read more
by Ernst & Young
As the specialty pharmaceutical sector sees its ability to pursue large acquisitions evaporate, long-promised organic growth from big pharma new drug launches has finally arrived. But a renewed focus on value-based pricing, staunch competition across key therapeutic battlefields and consolidating payer clout may weaken the industry’s ability to reach revenue targets for both new and legacy therapeutics. […] Read more
EY’s Firepower Index and Growth Gap Report 2016 By Andrew Forman – Ernst & Young Contributors: Jeff Greene, Chris Morrison As the specialty pharmaceutical sector
Trainings
In order to become a charterholder you need to complete one of the IMAA programs
